Featured article: GOLD 2017 recommendations for COPD patients: toward a more personalized approach

New Content ItemThe Global Initiative for Chronic Obstructive Lung Disease (GOLD) is an international committee of experts who periodically update the knowledge on the diagnosis and management of chronic obstructive pulmonary disease (COPD), based on an extensive scientific discussion and published evidence in the literature. Every 5-year the document is extensively revised so representing a formal new update by GOLD committee on the disease.

Read the article


View all articles

View all articles

Aims and scope

COPD Research and Practice publishes basic and clinical research and review articles relating to the development, progression and treatment of chronic obstructive pulmonary disease (COPD) and related disorders.

The translational aspect of the journal facilitates discussion and dissemination of knowledge which allows new ideas to be exchanged between clinicians and researchers alike from bench to bedside. Both the open access format and high profile Editorial Board enable the distribution of research to an international audience ensuring high visibility and a wide reach for all publications.

The journal covers all areas of COPD research and practice but also has several special sections:

  • Epidemiology
  • Comorbidities
  • Etiology
  • Genetics
  • Rehabilitation and Therapeutics

Sign up to receive article alerts

COPD Research and Practice is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.

COPD: on the rise, but still underrated

World COPD Day aims to raise awareness of chronic obstructive pulmonary disease (COPD) and the improvement of its care.

To mark World COPD Day we invited Dr. Alexandru Corlateanu to give us a background on COPD and how it can be managed. He also tells us about World COPD Day and what its aims are.

Read the blog post here

Editor’s profile

Professor Mario Cazzola is Professor of Respiratory Medicine and Chief of the Respiratory Clinical Pharmacology Unit at the University of Rome Tor Vergata, Italy, and Honorary Professor at the Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, London, UK. His research interests include chronic obstructive airway disorders and their pharmacotherapy. He has published more than 310 publications in peer-reviewed journals. He founded Therapeutic Advances in Respiratory Diseases and served as its first Editor-in-chief. He serves as the Editor-in-Chief of Pulmonary Pharmacology & Therapeutics; an Associate Editor of Respiratory Medicine, Respiratory Research, and Clinical Investigation; a Section Editor for The Open Respiratory Medicine Journal; and is a member of various editorial boards (Lancet Respiratory Medicine, Drugs, COPD, Respiration). He was the Director of Postgraduate Courses at the European Respiratory Society. Currently, he is the Chairman of the Southern Europe Chapter at Interasma and of the Mediterranean COPD Forum, and a member of the steering committee of the Airway Disorders Network at the American College of Chest Physicians.